Efficacy of Centervention-ATOD: An Implementation Tool for Dissemination of Evidence-based Programs for Substance Abuse

NCT03084406 | Completed

• 1 other identifier: R44DA035014
• Study Type: interventional
• Target: 327
• Locations: 1 country
• Sites: 1

Brief Summary

The pilot test of Centervention-ATOD, a customizable suite of online tools specifically designed to support quality implementation and sustainability of any ATOD-EBP within real-world service settings, will evaluate whether the product awards additive benefits in provider implementation proficiency and efficacy, quality of implementation delivery, and EBP (i.e., Free Talk or CHOICE) outcomes compared to traditional implementation methods. Additionally, a cost-effectiveness study will be conducted to assess whether the implementation support strategy (i.e., Centervention-ATOD) is more cost-effective than traditional implementation methods.

Conditions

Substance Abuse

Keywords

Substance Abuse; Implementation Science; Evidence-based Practices

Outcome Measures

Primary Outcomes (10)

• Change in Provider EBP knowledge and MI skills

  Providers will take an EBP knowledge and MI skills test of 25 questions from a bank of questions produced by the EBP developer.

  1) prior to starting the trial (baseline) but after completing the training for the EBP and the ISS 2) within two weeks of completing the last session of the EBP

• Change In Provider Self-Efficacy for EBP Implementation

  Providers will report their self-efficacy regarding EBP implementation. Ten items from two subscales (change commitment, change efficacy) of the Readiness for Change instrument (Shea et al.) will be used to measure self-efficacy to implement the EBP.

  1) prior to starting the trial (baseline) but after completing the training for the EBP and the ISS 2) within two weeks of completing the last session of the EBP

• Provider Fidelity to EBP - Component Coverage

  Providers will report on their component coverage after each session during the 5 or 6 weeks of the program trial by indicating for each component whether it was fully completed, partially completed, or not completed.

  during the 5 or 6 week EBP trial, after each session is completed

• Provider Fidelity to EBP - MI Quality of Delivery

  Providers will report on their MI quality of delivery after each session during the 5 or 6 weeks of the program trial by completing a 10-item MI Self-Assessment questionnaire from the MIA Step Manual (NIDA/SAMHSA).

  during the 5 or 6 week EBP trial, after each session is completed

• Provider Fidelity to EBP - Participant Responsiveness

  Providers will report on participant responsiveness after every session during the 5 or 6 weeks of the program trial by completing a 6-item questionnaire measuring youth engagement.

  during the 5 or 6 week EBP trial, after each session is completed

• Provider Perceptions of EBP - Usage Rating

  Providers will report on their perceptions of the EBP by completing 26 items from the revised Usage Rating Profile-Intervention (URPI-R) that will measure: (a) acceptability, (b) understanding, (c) feasibility, (d) system climate, and (e) system support.

  within two weeks after completing the last session of the EBP

• Provider Perceptions of EBP - Appropriateness

  Providers will report on their perceptions of the EBP by completing eight items from the Training/Practice Acceptability/Feasibility/Appropriateness Scale (TPA) measuring appropriateness.

  within two weeks after completing the last session of the EBP

• Provider Perceptions of EBP - Adoption

  Providers will report on their EBP usage and adoption by completing the result demonstrability subscale from the Adoption of an IT innovation (AITI).

  within two weeks after completing the last session of the EBP

• Change in Youth Beliefs, Attitudes toward Substance Use

  Youth will report on their attitudes and beliefs toward substance use by completing questions obtained from the EBP developer. These questions will assess: (a) beliefs and attitudes, (b) perceived benefits, (c) perceived normative substance use, (d) intention to use in the future, (e) youth motivation, and (f) readiness to change.

  1) prior to starting the trial (baseline) 2) within two weeks after completing the last session of the EBP.

• Change in Youth Substance Use

  Youth will report on their substance use by completing questions obtained from the EBP developer. These questions will assess: a) last 30 days use, b) negative consequences due to substance use, c) intention to use in the future, d) resistance self-efficacy, and e) coping strategies.

  1) prior to starting the trial (baseline) 2) within two weeks after completing the last session of the EBP.

Secondary Outcomes (7)

• Provider Fidelity to ISS

  during training and during the 5 or 6 week EBP trial as providers use the ISS

• Provider Perceptions of ISS - Usage Rating

  within two weeks of completing the last session of the EBP

• Provider Perceptions of ISS - Appropriateness

  within two weeks of completing the last session of the EBP

• Provider Perceptions of ISS - Adoption

  within two weeks after completing the last session of the EBP

• Provider Perceptions of ISS Characteristics - System Usability

  within two weeks of completing the last session of the EBP

Study Arms (2)

Enhanced Implementation (EI)

EXPERIMENTAL

Providers in the Free Talk EI condition will receive access to CV-ATOD. They will participate in an online training course that mirrors the training in the IAU condition. EI providers will also receive access to interactive online exercises and practice activities within the training module. They will have online access to the Free Talk: Group MI for Teens searchable manual and materials via CV-ATOD. Providers may complete an optional CE course following the completion of the training module. EI providers will have access to all EBP implementation tools provided by CV-ATOD. Student providers in the CHOICE EI condition will receive access to CV-ATOD. They will participate in an online training course that mirrors the training in the IAU condition. However, EI providers will also receive access to interactive online exercises and practice activities within the training module. They will have online access to the CHOICE: Group MI for Teens searchable manual and materials via CV-ATOD.

Other: Centervention-ATOD (CV-ATOD)

Implementation As Usual (IAU)

NO INTERVENTION

CMH providers in the Free Talk IAU condition will receive access to the Group MI for Teens website that provides asynchronous, self-paced training videos as well as downloadable intervention materials and resources. CMH providers in this condition are only required to watch the first two training videos before receiving access to download the Free Talk training manual and materials. Providers may also complete an optional CE course following the completion of all training videos. Student providers in the CHOICE IAU condition will receive access to the Group MI for Teens website that provides online training videos as well as downloadable intervention materials and resources. IAU providers are only required to watch the first two training videos before receiving access to download the CHOICE training manual and materials. Providers may also complete an optional EBP knowledge test following the completion of all training videos.

Interventions

Centervention-ATOD (CV-ATOD) OTHER

A customizable suite of online tools specifically designed to support quality implementation and sustainability of any ATOD-EBP within real-world service settings.

Enhanced Implementation (EI)

Eligibility Criteria

• Age: 11 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Licensed CMH Provider to youth between ages 14 -17 for Free Talk EI/TAU
• Students enrolled in local University Clinical Programs for CHOICE EI/TAU
• Between ages 14 -17 for Free Talk EI/TAU, Between ages 11 -14 for CHOICE EI/TAU
• For Free Talk EI/TAU, youth may have experimented with or currently use alcohol or other drugs.
• For CHOICE EI/TAU, youth may, or may not, have considered ATOD experimentation.

Sponsors & Collaborators

• 3-C Institute for Social Development: lead

Study Sites (1)

3C Institute

Durham, North Carolina, 27713, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• Melissa E DeRosier, PhD

  CEO

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Model Details: The pilot test will employ a Hybrid Type II study design to simultaneously test the clinical evidence-based program as well as the implementation strategy.

Study Record Dates

• First Submitted: March 2, 2017
• First Posted: March 21, 2017
• Study Start: February 13, 2017
• Primary Completion: December 22, 2017
• Study Completion: December 22, 2017
• Last Updated: November 1, 2018

Record last verified: 2018-10

Locations

US (1)